Showing 606 news articles about New & experimental HIV treatments

Filters Content type: News Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

The search for a cure

Research helps explain how vedolizumab antibody therapy leads to sustained viral remission

News
23 March 2017
New & experimental HIV treatments

Several new candidates in HIV drug pipeline discussed at conference

News
15 March 2017
New & experimental HIV treatments

Dolutegravir monotherapy fails to maintain HIV viral suppression, but dolutegravir + lamivudine looks good

News
9 March 2017
New & experimental HIV treatments

New HIV capsid inhibitors show high potency and prolonged activity in early studies

News
3 March 2017
New & experimental HIV treatments

Monoclonal antibodies show promise for HIV-positive people with limited treatment options

News
22 February 2017
New & experimental HIV treatments

New NNRTI doravirine shows good efficacy in phase 3 study

News
19 February 2017
Treatment simplification strategies

Dual antiretroviral regimen maintains durable HIV suppression after switch

News
15 February 2017
New & experimental HIV treatments

Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment

News
14 February 2017
PrEP science

The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study

News
11 November 2016
New & experimental HIV treatments

Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV

News
4 November 2016
Treatment simplification strategies

Four days on, three days off HIV treatment controls viral load in French pilot study

News
3 November 2016
Treatment simplification strategies

Darunavir/ritonavir & lamivudine matches triple-drug therapy

News
31 October 2016
New & experimental HIV treatments

New long-acting fusion inhibitor albuvirtide plus boosted protease inibitor matches standard triple-drug therapy

News
28 October 2016
The search for a cure

Crohn’s disease drug produces long-lasting viral undetectability and T-cell restoration off treatment in monkeys

News
14 October 2016
Access to healthcare

German medicines watchdog rejects ‘new tenofovir’ pill

News
22 August 2016
New & experimental HIV treatments

Once-daily raltegravir works as well as twice-daily for initial HIV treatment

News
26 July 2016
New & experimental HIV treatments

Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment

News
25 July 2016
New & experimental HIV treatments

Long-acting injectable drugs work well for HIV maintenance therapy

News
22 July 2016
The search for a cure

HIV will only be cured with combinations too, conference delegates hear

News
20 July 2016
New & experimental HIV treatments

New integrase inhibitor bictegravir looks promising in early studies

News
6 July 2016
New & experimental HIV treatments

PRO 140 antibody injections maintain viral suppression in phase 2 study

News
28 June 2016
New & experimental HIV treatments

Long-acting oral antiretroviral MK-8591 could represent 'paradigm shift' in HIV treatment and prophylaxis

News
1 April 2016
The search for a cure

Gene therapy snips HIV out of infected cells and makes uninfected cells resistant

News
30 March 2016
New & experimental HIV treatments

Combination inhibitor BMS-986197 demonstrates good activity against HIV in early study

News
18 March 2016